474 related articles for article (PubMed ID: 15763125)
1. Mood and anxiety disorders in women with treated hyperthyroidism and ophthalmopathy caused by Graves' disease.
Bunevicius R; Velickiene D; Prange AJ
Gen Hosp Psychiatry; 2005; 27(2):133-9. PubMed ID: 15763125
[TBL] [Abstract][Full Text] [Related]
2. The Manitoba IBD cohort study: a population-based study of the prevalence of lifetime and 12-month anxiety and mood disorders.
Walker JR; Ediger JP; Graff LA; Greenfeld JM; Clara I; Lix L; Rawsthorne P; Miller N; Rogala L; McPhail CM; Bernstein CN
Am J Gastroenterol; 2008 Aug; 103(8):1989-97. PubMed ID: 18796096
[TBL] [Abstract][Full Text] [Related]
3. Smoking and other lifestyle factors and the risk of Graves' hyperthyroidism.
Holm IA; Manson JE; Michels KB; Alexander EK; Willett WC; Utiger RD
Arch Intern Med; 2005 Jul; 165(14):1606-11. PubMed ID: 16043678
[TBL] [Abstract][Full Text] [Related]
4. Use of administrative data for the surveillance of mood and anxiety disorders.
Kisely S; Lin E; Gilbert C; Smith M; Campbell LA; Vasiliadis HM
Aust N Z J Psychiatry; 2009 Dec; 43(12):1118-25. PubMed ID: 20001410
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of mood, anxiety, and substance-abuse disorders for older Americans in the national comorbidity survey-replication.
Gum AM; King-Kallimanis B; Kohn R
Am J Geriatr Psychiatry; 2009 Sep; 17(9):769-81. PubMed ID: 19700949
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of psychiatric disorders and premenstrual dysphoric symptoms in patients with experience of adverse mood during treatment with combined oral contraceptives.
Segebladh B; Borgström A; Odlind V; Bixo M; Sundström-Poromaa I
Contraception; 2009 Jan; 79(1):50-5. PubMed ID: 19041441
[TBL] [Abstract][Full Text] [Related]
7. [Quality of life in Graves' ophthalmopathy (continuation of research)].
Warmuz-Stangierska I; Czarnywojtek A; Stangierski R; Sowiński J
Przegl Lek; 2004; 61(8):857-9. PubMed ID: 15789917
[TBL] [Abstract][Full Text] [Related]
8. [Chronic distress syndrome in patients with Graves' disease].
Scheffer C; Heckmann C; Mijic T; Rudorff KH
Med Klin (Munich); 2004 Oct; 99(10):578-84. PubMed ID: 15490073
[TBL] [Abstract][Full Text] [Related]
9. Women, anxiety and mood: a review of nomenclature, comorbidity and epidemiology.
Alexander JL; Dennerstein L; Kotz K; Richardson G
Expert Rev Neurother; 2007 Nov; 7(11 Suppl):S45-58. PubMed ID: 18039068
[TBL] [Abstract][Full Text] [Related]
10. Comorbidity of cardiovascular diseases with mood and anxiety disorder: a population based 4-year study.
Huang KL; Su TP; Chen TJ; Chou YH; Bai YM
Psychiatry Clin Neurosci; 2009 Jun; 63(3):401-9. PubMed ID: 19566773
[TBL] [Abstract][Full Text] [Related]
11. Use of anti-thyroid drugs in euthyroid pregnant women with previous Graves' disease.
McNab T; Ginsberg J
Clin Invest Med; 2005 Jun; 28(3):127-31. PubMed ID: 16021986
[TBL] [Abstract][Full Text] [Related]
12. Classifying mood disorders by age-at-onset instead of polarity.
Benazzi F
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb; 33(1):86-93. PubMed ID: 18992784
[TBL] [Abstract][Full Text] [Related]
13. Outcome and impact of mental disorders in primary care at 5 years.
Jackson JL; Passamonti M; Kroenke K
Psychosom Med; 2007 Apr; 69(3):270-6. PubMed ID: 17401055
[TBL] [Abstract][Full Text] [Related]
14. Methamphetamine use by incarcerated women: comorbid mood and anxiety problems.
Vik PW
Womens Health Issues; 2007; 17(4):256-63. PubMed ID: 17544297
[TBL] [Abstract][Full Text] [Related]
15. Anxiety and mood disorders in narcolepsy: a case-control study.
Fortuyn HA; Lappenschaar MA; Furer JW; Hodiamont PP; Rijnders CA; Renier WO; Buitelaar JK; Overeem S
Gen Hosp Psychiatry; 2010; 32(1):49-56. PubMed ID: 20114128
[TBL] [Abstract][Full Text] [Related]
16. [Sociodemographic profiles, addictive and mental comorbidity in cannabis users in an outpatient specific setting].
Guillem E; Pelissolo A; Vorspan F; Bouchez-Arbabzadeh S; Lépine JP
Encephale; 2009 Jun; 35(3):226-33. PubMed ID: 19540408
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of mood and anxiety disorders in the community: results from the Israel National Health Survey.
Levinson D; Zilber N; Lerner Y; Grinshpoon A; Levav I
Isr J Psychiatry Relat Sci; 2007; 44(2):94-103. PubMed ID: 18080646
[TBL] [Abstract][Full Text] [Related]
18. Psychiatric manifestations of Graves' hyperthyroidism: pathophysiology and treatment options.
Bunevicius R; Prange AJ
CNS Drugs; 2006; 20(11):897-909. PubMed ID: 17044727
[TBL] [Abstract][Full Text] [Related]
19. [Psychosomatic aspects of hyperthyroidism with special reference to Basedow's disease. An overview].
Rodewig K
Psychother Psychosom Med Psychol; 1993 Aug; 43(8):271-7. PubMed ID: 8378518
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of anxiety disorders in men and women with established coronary heart disease.
Todaro JF; Shen BJ; Raffa SD; Tilkemeier PL; Niaura R
J Cardiopulm Rehabil Prev; 2007; 27(2):86-91. PubMed ID: 17558244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
